Shares of Valneva SE (NASDAQ:VALN – Get Free Report) gapped down before the market opened on Tuesday after Guggenheim lowered their price target on the stock from $17.00 to $15.00. The stock had ...

Valneva responds to French govt’s call for supply of chikungunya vaccine, Ixchiq: Saint Herblain, France Wednesday, March 26, 2025, 17:00 Hrs [IST] Valneva SE, a specialty vacci ...

Valneva (NASDAQ:VALN – Get Free Report) had its target price dropped by research analysts at Guggenheim from $17.00 to $15.00 in a research note issued to investors on Monday,Benzinga reports. The ...

SE announced earlier that it is responding to the chikungunya outbreak that is rapidly intensifying in France’s Island of La ...

Thousands have been infected and two have been killed by the debilitating, mosquito-borne virus in the space of a few weeks ...

The agency has published a list of 24 high-risk infectious diseases as a reference tool for funders and researchers.

Valneva will work with local health authorities and wholesalers on the French island territory to distribute the vaccines.

Surrozen pivots focus, CBC Group raises $1B fund, CG Oncology reports bladder cancer data, Opus gets $21.5M, and Valneva sells chikungunya vaccine to France.

Chikungunya cases have spiked substantially in La Réunion since early 2025, with 8,600 cases recorded and almost 3,000 new cases during the week of March 3 to 9, 2025 1. Similar to the 2005-2006 ...

A mosquito-borne disease called chikungunya has killed two elderly people on France's Reunion Island, local authorities said ...

Valneva anticipates total product sales of €170 million to €180 million and total revenues of €180 million to €190 million for 2025, driven by increased IXCHIQ sales and growth in IXIARO and DUKORAL.

Get detailed information on chikungunya, its clinical assessment and treatment. Reports of hospitalization for cardiac or neurologic events following vaccination with IXCHIQ in persons 65 years of age ...